Author:
Galstyan G M,Polevodova O A,Gavrish A Yu,Polyanskaya T Yu,Zorenko V Yu,Sampiev M S,Biryukova L S,Model S V,Gorgidze L A,Savchenko V G
Abstract
The paper describes 4 clinical cases of thrombotic events (pulmonary embolism, deep vein thrombophlebitis, acute myocardial infarction, ischemic stroke) that have occurred in patients with hemophilia. It discusses the possible causes of their development and methods for their prevention and treatment. Controlled natural hypocoagulation, in which the dose of an administered deficient factor decreases to such an extent that in order to maintain the safe level of hypocoagulation (plasma factor activity is 15—20%; activated partial thromboplastin time is 1.5—2 times normal values), is proposed as one of the treatment options.
Subject
General Medicine,Endocrinology, Diabetes and Metabolism,History,Family Practice
Reference40 articles.
1. Абдулаев Г.М. Гемофилия. Баку, Азербайджан; 1973.
2. Чернов В.М., Румянцев А.Г. Актуальные проблемы гемофилии в исследованиях российских ученых. Вопросы гематологии/иммунологии и иммунопатологии в педиатрии. 2008;5-15.
3. Schulman S. The Act of Balancing Bleeding versus Thrombosis. Cardiology Rounds. 2005;9:302-308
4. Aronson D. Cause of death in hemophilia A patients in the United States from 1968 to 1979. American Journal of Hematology. 1988;27:7-12. https://doi.org/10.1002/ajh.2830270103
5. Dolan G. The challenge of an ageing hemophilic population. Haemophilia. 2010;16:11-16. https://doi.org/10.1111/j.1365-2516.2010.02287.x
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Otogenic Sinus Thrombosis and Hemophilia: A Clinical Case;Kuban Scientific Medical Bulletin;2023-06-22
2. Reference values of activated partial thromboplastin time, Quick`s value, INR, thrombin time, fibrinogen, antithrombin and II, V, VII, VIII, IX, X, XI and XII coagulation factors determined with automated Sysmex CS-2000i analyzer;Medical alphabet;2023-03-29
3. Frequency and risk factors of thromboembolic complications in patients with inflammatory bowel diseases;Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.;2022-12-01
4. Frequency and risk factors for thromboembolic complications in patients with inflammatory bowel diseases;Terapevticheskii arkhiv;2022-02-15
5. Acute arterial thrombosis in hemophilia with inhibitory antibodies;Khirurgiya. Zhurnal im. N.I. Pirogova;2022